Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats - Wikidata - awgldk - TriplyDB

Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats

Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats

http://www.wikidata.org/entity/Q41873186

about

Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes Potential role of dipeptidyl peptidase IV in the pathophysiology of heart failure Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: A retrospective cohort study The nonglycemic actions of dipeptidyl peptidase-4 inhibitors Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial.Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes.Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells.DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.Treating Diabetes in Patients with Heart Failure: Moving from Risk to Benefit.Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: An experimental study.New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data.Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines.G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics.Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging

P2860

Q26785454-519ECF33-A903-4CCE-BF08-FAE9D9C4F084 Q26829634-3AC3B4F2-BE49-48DC-9910-C8A2E8B59F4F Q33833732-D9351804-E667-4709-A400-12B6933DFCD8 Q34029715-85016D81-9A5A-433F-AF70-9C1ECEA318AC Q35759370-60CE6CA3-D2BE-4C0E-B7C1-33D53DF761E8 Q35842591-23ACFD21-FF3E-4C6C-B668-53BE38CCBEF5 Q36687153-129C8B81-2ADA-4976-8F4F-7B5F0F29C85E Q38413395-6C964D39-AB76-4889-BA39-81E6454425E1 Q38836416-B71980CA-216F-4CA7-A2F2-5204425E1280 Q42319765-D415B6B8-03C4-4CED-9805-68CCDB3F134B Q47113843-B525B3CA-E323-4C26-A0B8-33C32677745E Q47265349-7030DE05-9C45-4335-9491-86471F3F9BD1 Q47941940-C838999F-3DE3-4C9A-A636-6D6F16411F25 Q48229830-00959DD7-4057-4159-8C36-9EF4EA29C4EB Q58691975-879E2E74-7BAC-496A-BDA8-321294561A0F Q58790122-18DE827F-D0F7-490B-834B-210E982F3008

P2860

Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats

http://www.wikidata.org/entity/Q41873186

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Effect of vildagliptin, a dipe ...... adrenergic stimulation in rats

@en

type

label

Effect of vildagliptin, a dipe ...... adrenergic stimulation in rats

@en

prefLabel

Effect of vildagliptin, a dipe ...... adrenergic stimulation in rats

@en

P1433

Q41873186-70256D34-CB06-453A-A59E-95D79724E2EB

P1476

Q41873186-B00AFDE2-966B-480D-9815-770AF9A6B54E

P2093

Q41873186-29862845-0009-4AB6-B9A6-00241D11B79E

Q41873186-45C890FA-A856-404A-830C-9B57C5947F5D

Q41873186-78F7286B-41FB-4100-921E-97C48F06D16C

Q41873186-8D952A04-A019-43DF-B570-7B030D30B4B2

Q41873186-AD3DB05B-C921-4B67-BD95-B1DE4A19FCB1

Q41873186-B1FBD2E5-733B-46A7-9162-F37715E5DAFB

Q41873186-C02C9D9B-0ACC-4D90-998A-AC7C34D264A4

Q41873186-C1FB93DD-5027-4E8B-95D8-C9D7D42E3B7B

Q41873186-D81B3B32-F101-4174-8CF8-8237A7F5904F

Q41873186-E6B55B71-F9F1-48DD-816E-90ADE651F497

P2860

Q41873186-010C0716-912A-406F-8B21-DA38A374DB06

Q41873186-01AED59A-2163-4AE8-8107-1B37B2A3D5D0

Q41873186-0417276F-A797-4FA5-B780-C45579A32F92

Q41873186-065BB291-23D4-4CF4-B52A-067627AFB4B2

Q41873186-098A17BE-CF1A-46D6-962D-5874AE3E344A

Q41873186-0C88B7D7-58D2-405B-8DC3-53C7C34BDD7D

Q41873186-0EEE8CEB-70AB-4C05-AFF4-D78F997A3E60

Q41873186-1ADD6C71-E544-4541-A266-BC9B0E3D2E60

Q41873186-1D0DB97A-151D-4ABA-964C-1F759DF9995E

Q41873186-21BBAC68-ECE0-4F1E-9274-50381E8D7CE5

P2888

Q41873186-65754DB0-4636-4F8D-A2B1-9F1085196650

P304

Q41873186-BFED9FF7-0BB3-4C3C-B61B-BEBB4635435D

P31

Q41873186-20C7701A-70F8-4E29-B20B-F94A9F1C7EA6

P356

Q41873186-28237EB0-7AF6-41E3-A409-2D161916BEC4

P407

Q41873186-8DBA26F5-01C5-44DD-8491-C5AA39FBB0FF

P478

Q41873186-7B9E727B-1BCA-45E8-895E-51DCE2AA20F6

P50

Q41873186-E4C8DFE9-CC1E-4C35-AF72-190034C00E76

P577

Q41873186-E4410754-12B1-46B9-BD94-8B021FFA7926

P5875

Q41873186-DA97B47B-A4F8-4203-BFA3-16FDB954D13F

P6179

Q41873186-8812A4A9-1684-4CA0-8BF8-5D16FF84563F

P698

Q41873186-79BF8EE8-CB25-48EB-B1D7-C0124E279E1B

P932

Q41873186-1DA7407D-F0EC-4999-AF07-A938FBB9E9D7

P356

1475-2840-13-43

P1433

Cardiovascular Diabetology

P1476

Effect of vildagliptin, a dipe ...... adrenergic stimulation in rats

@en

P2093

Daiji Miura

http://www.w3.org/2001/XMLSchema#string

Hiroki Oe

http://www.w3.org/2001/XMLSchema#string

Hiroki Sugiyama

http://www.w3.org/2001/XMLSchema#string

Hiroshi Ito

http://www.w3.org/2001/XMLSchema#string

Kaoru Akazawa

http://www.w3.org/2001/XMLSchema#string

Kazufumi Nakamura

http://www.w3.org/2001/XMLSchema#string

Masashi Yoshida

http://www.w3.org/2001/XMLSchema#string

Satoshi Akagi

http://www.w3.org/2001/XMLSchema#string

Tomoko Yonezawa

http://www.w3.org/2001/XMLSchema#string

Toru Miyoshi

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy

Increased passive stiffness of cardiomyocytes in the transverse direction and residual actin and myosin cross-bridge formation in hypertrophied rat hearts induced by chronic β-adrenergic stimulation.

Vildagliptin improves endothelium-dependent vasodilatation in type 2 diabetes

Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK

Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure.

Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet.

Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation.

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

P2888

1475-2840-13-43

P304

43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-13-43

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260168151

http://www.w3.org/2001/XMLSchema#string

P6179

1019770115

http://www.w3.org/2001/XMLSchema#string

P698

24521405

http://www.w3.org/2001/XMLSchema#string

P932

3926272

http://www.w3.org/2001/XMLSchema#string